In vivo transfer of antisense oligonucleotide against urinary kininase blunts deoxycorticosterone acetate-salt hypertension in rats

作者: Izumi Hayashi , Masataka Majima , Tomoe Fujita , Toshiaki Okumura , Yuji Kumagai

DOI: 10.1038/SJ.BJP.0703634

关键词:

摘要: We have previously reported that the renal kallikrein-kinin system suppressed development of deoxycorticosterone acetate (DOCA)-salt hypertension. Kinins were degraded in kidney mainly by carboxypeptidase Y (CPY)-like kininase. Blockade kinin degradation may reduce hypertension developmental stage. constructed an antisense oligonucleotide against rat CPY homologue (5'-CAT-CTC-TGC-TTC-CTT-GTG-TC-3', AS) and its randomized control (5'-TCC-TTC-CTG-CTT-GAG-TTC-CT-3', RC), prepared HVJ-liposome complex prolongs increases effectiveness oligonucleotide. Antisense was transfected (25 nmole rat(-1), terms nucleotide) into from artery. Blood pressure measured through a catheter inserted abdominal aorta. Mean blood (MBP) DOCA-salt treated (for 2 weeks) Sprague Dawley strain rats 130+/-3 mmHg (n=11), reduced significantly (P<0.05) more AS transfection (122+/-4 mmHg, n=6) than RC treatment (137+/-6 n=5) 4 days after transfection. This reduction MBP accompanied increased urinary sodium excretion (AS, 8.4+/-1.5 mmole day(-1); RC, 4.6+/-0.5 day(-1), P<0.05) CPY-like kininase activity. Ebelactone B (5 mg kg(-1), twice day, p.o.), inhibitor for kininase, also induced natriuresis to same degree as AS. Lisinopril, angiotensin converting enzyme (ACE) failed elevated MBP. These results suggest contribution ACE degrade kidney, knockdown partly prevent

参考文章(34)
N J Galjart, N Gillemans, D Meijer, A d'Azzo, Mouse "protective protein". cDNA cloning, sequence comparison, and expression. Journal of Biological Chemistry. ,vol. 265, pp. 4678- 4684 ,(1990) , 10.1016/S0021-9258(19)39616-4
A Scaloni, W.M. Jones, D Barra, M Pospischil, S Sassa, A Popowicz, L.R. Manning, O Schneewind, J.M. Manning, Acylpeptide hydrolase: inhibitors and some active site residues of the human enzyme. Journal of Biological Chemistry. ,vol. 267, pp. 3811- 3818 ,(1992) , 10.1016/S0021-9258(19)50598-1
Y Kaneda, K Iwai, T Uchida, Introduction and expression of the human insulin gene in adult rat liver. Journal of Biological Chemistry. ,vol. 264, pp. 12126- 12129 ,(1989) , 10.1016/S0021-9258(18)63828-1
H L Jackman, F L Tan, H Tamei, C Beurling-Harbury, X Y Li, R A Skidgel, E G Erdös, A peptidase in human platelets that deamidates tachykinins. Probable identity with the lysosomal "protective protein". Journal of Biological Chemistry. ,vol. 265, pp. 11265- 11272 ,(1990) , 10.1016/S0021-9258(19)38586-2
Masataka Majima, Keiichi Adachi, Yoshikazu Kuribayashi, Susumu Mizogami, Makoto Katori, Increase in Vascular Sensitivity to Angiotensin II and Norepinephrine after Four-Day Infusion of 0.3 M Sodium Chloride in Conscious Kininogen-Deficient Brown Norway Katholiek Rats Japanese Journal of Pharmacology. ,vol. 69, pp. 149- 158 ,(1995) , 10.1254/JJP.69.149
R Morishita, G H Gibbons, K E Ellison, M Nakajima, H von der Leyen, L Zhang, Y Kaneda, T Ogihara, V J Dzau, Intimal hyperplasia after vascular injury is inhibited by antisense cdk 2 kinase oligonucleotides. Journal of Clinical Investigation. ,vol. 93, pp. 1458- 1464 ,(1994) , 10.1172/JCI117123
R. Morishita, G. H. Gibbons, K. E. Ellison, M. Nakajima, L. Zhang, Y. Kaneda, T. Ogihara, V. J. Dzau, Single intraluminal delivery of antisense cdc2 kinase and proliferating-cell nuclear antigen oligonucleotides results in chronic inhibition of neointimal hyperplasia Proceedings of the National Academy of Sciences of the United States of America. ,vol. 90, pp. 8474- 8478 ,(1993) , 10.1073/PNAS.90.18.8474
Marcos E. Alfie, David H. Sigmon, Silvia I. Pomposiello, Oscar A. Carretero, Effect of High Salt Intake in Mutant Mice Lacking Bradykinin-B2 Receptors Hypertension. ,vol. 29, pp. 483- 487 ,(1997) , 10.1161/01.HYP.29.1.483